Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The heterodimeric cyclin B/Cdc2 protein kinase governs entry into mitosis, and can be negatively regulated through p53-mediated transcriptional induction of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1). Ectopic expression of p21(WAF1/CIP1) in cultured cells has been shown previously to influence the subcellular distribution of the cyclin-dependent kinases (CDKs) including Cdc2. In this study, we have examined the subcellular localisation of Cdc2, cyclin B and p21(WAF1/CIP1) by immunohistochemistry in a well characterised series of primary breast cancers. Surprisingly, p21(WAF1/CIP1) was predominantly cytoplasmic in many of the tumours, where it was associated with high p53 levels; cytoplasmic p21(WAF1/CIP1) and high cyclin B levels were also significant predictors of poor prognosis. We conclude that breast tumorigenesis may be characterised by abnormalities in pathways determining not only levels of expression of key regulatory molecules, but also their subcellular localisation. Investigation of the subcellular distribution of cell cycle regulatory proteins, particularly p21(WAF1/CIP1), could provide valuable prognostic markers in breast cancer.

Type

Journal article

Journal

Eur J Cancer

Publication Date

12/2001

Volume

37

Pages

2405 - 2412

Keywords

Adult, Aged, Aged, 80 and over, Breast Neoplasms, CDC2 Protein Kinase, Carcinoma, Ductal, Breast, Cyclin B, Cyclin-Dependent Kinase Inhibitor p21, Cyclins, Disease-Free Survival, Humans, Immunohistochemistry, Lymphatic Metastasis, Middle Aged, Multivariate Analysis, Neoplasm Proteins, Neoplasm Recurrence, Local, Predictive Value of Tests, Tumor Suppressor Protein p53